Video
28 Apr 2021

Bushu Pharma New Cold Chain Center

JPG 162 kB
Watch Video

Bushu Pharma helps improve the packaging and storing process which must be validated to ensure that there is no negative impact to the safety, efficacy or quality of the drug.
Through our Cold Chain logistics service, we enable the market expansion for temperature-controlled bio-pharmaceuticals (maintained at 2℃ to 8℃) to the Japan market, as well as to countries across Asia and beyond. We store and transport pharmaceuticals in line with each product's specific storage and security requirements, maintaining cold chain integrity throughout each step of the delivery process.

Read more Show less
Content provided by our supplier

Bushu Pharmaceuticals Ltd.

  • JP
  • 2015
    On CPHI since
View company profile

Other Content from Bushu Pharmaceuticals Ltd. (2)

  • Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

    News Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

    - “Gateway to Asia” Contract Manufacturing Organization (CMO) Agreement to Double Volume of Drugs Produced for Amgen by Bushu Pharma -
    25 Nov 2021
  • New SCM service Gateway to Asia

    Brochure New SCM service "Gateway to Asia"

    Bushu Pharma's "Gateway to Asia" service supports customers in their desire to launch new products in Japan and across the larger Asian region. Our Gateway to Asia service lets international pharmaceutical companies import bulk products into Japan for quality inspection, labeling, packaging and distribution throughout Japan and other Asian countries. The service lets you focus on your core businesses and avoid having to deal with the difficult process of managing lead-time, temperature, security, inventory, packaging and urgent order handling across multiple markets.
    Collectively, our services offers reduction of lead time from purchase order to shipping, financial and physical flow, oversight of inventory management for Asian markets, forecast review, and planning and operations based in GMP expertise.